Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Chloroquine phosphate prices in Germany, the highest-cost reporting region, rose 7.0% in H1 2026, recovering from USD 41.6/KG in Q1 to USD 44.5/KG by Q2 as recovering tropical disease season procurement and firmer synthesis intermediate costs reversed the H2 2025 post-COVID demand normalisation softening. Globally, the average rose from USD 28.46/KG in Q1 to USD 30.45/KG in Q2, a 7.0% gain. For H2 2026, a global average of USD 30.80-34.00/KG is expected, with continued firming on antimalarial season procurement and growing autoimmune and tropical disease sector demand.
Chloroquine phosphate is the phosphate salt form of chloroquine, a 4-aminoquinoline compound synthesised through a multi-step chemical route starting from 4,7-dichloroquinoline and 4-amino-1-pentylamine intermediates. The largest pull comes from antimalarial pharmaceutical formulations, where chloroquine phosphate remains a first-line treatment and prophylaxis option for Plasmodium vivax and chloroquine-sensitive Plasmodium falciparum malaria in tropical and subtropical disease-endemic regions across Sub-Saharan Africa, South and Southeast Asia, and Central and South America. Additional demand comes from autoimmune disease management where hydroxychloroquine is widely prescribed but chloroquine retains use in lupus erythematosus and rheumatoid arthritis management, strategic stockpiling and pandemic preparedness programmes following the 2020 COVID-19 demand surge, and veterinary antiprotozoal applications. The 4,7-dichloroquinoline and diethylamine synthesis intermediate costs, tropical disease seasonal procurement cycles, and regional API production capacity all feed into the price.
The balance of supply and demand for chloroquine phosphate through H2 2026 leans cautiously firm. Synthesis intermediate costs firmed from Middle East chemical supply chain disruptions. Antimalarial season procurement in Sub-Saharan Africa and South Asia, autoimmune disease therapy demand, and strategic stockpiling by health ministries are maintaining consistent buying following the H2 2025 post-pandemic demand normalisation.
The main upside risk is a sharp outbreak of chloroquine-sensitive malaria in high-burden regions alongside accelerating autoimmune disease management demand. The main downside risk is a renewed surge in Chinese chloroquine phosphate production capacity and inventory build that limits the global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 30.80 - 34.00 | Antimalarial season and synthesis cost support |
| United States | 32.80 - 36.00 | Steady autoimmune and stockpiling demand holds firm |
| China | 22.80 - 26.00 | Large API capacity keeps it the most affordable |
| Germany | 44.80 - 48.00 | High synthesis and energy costs keep it the most expensive |
| India | 31.80 - 35.00 | Growing antimalarial and autoimmune demand holds a firm middle |
US chloroquine phosphate prices averaged USD 36.7/KG in Q2 2026, up 7.0% from USD 34.3/KG in Q1 2026. Recovering antimalarial season and autoimmune disease procurement and firmer synthesis intermediate costs drove consistent buying through the quarter.
Why did the price of Chloroquine Phosphate change in Q2 2026 in the United States?
Recovering antimalarial prophylaxis and treatment procurement from global health organisations lifted buying. Autoimmune disease management formulation demand maintained consistent pharmaceutical procurement. Firmer synthesis intermediate costs raised the production cost floor near USD 36.7/KG.
Chinese chloroquine phosphate prices averaged USD 23.6/KG in Q2 2026, up 6.8% from USD 22.1/KG in Q1 2026, the lowest among the tracked markets. Spring antimalarial export and domestic procurement lifted buying. Firmer domestic synthesis intermediate costs raised the production floor despite large domestic API capacity.
Why did the price of Chloroquine Phosphate change in Q2 2026 in China?
Spring antimalarial export procurement and domestic autoimmune formulation demand lifted buying from API producers. Firmer domestic synthesis intermediate costs raised the production cost floor. Large domestic chloroquine phosphate capacity kept China the most affordable source.
German chloroquine phosphate prices averaged USD 44.5/KG in Q2 2026, up 7.0% from USD 41.6/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering autoimmune disease and antimalarial season procurement maintained consistent buying.
Why did the price of Chloroquine Phosphate change in Q2 2026 in Germany?
Higher synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added import cost premiums to dichloroquinoline and amine intermediate supply chains. Recovering autoimmune disease and antimalarial prophylaxis procurement maintained consistent buying.
Indian chloroquine phosphate prices averaged USD 33.2/KG in Q2 2026, up 7.1% from USD 31.0/KG in Q1 2026. Growing antimalarial season and autoimmune formulation demand supported buying. Firmer synthesis intermediate costs raised the production floor through the quarter.
Why did the price of Chloroquine Phosphate change in Q2 2026 in India?
Growing domestic antimalarial treatment and autoimmune disease formulation demand lifted procurement from API producers. Firmer synthesis intermediate costs raised the production floor. Export demand from Sub-Saharan Africa and Southeast Asian markets provided additional buying support near USD 33.2/KG.
US chloroquine phosphate prices averaged USD 34.3/KG in Q1 2026, recovering from the H2 2025 trough. Recovering autoimmune and antimalarial procurement and firmer synthesis costs held the market near USD 34.3/KG.
Why did the price of Chloroquine Phosphate change in Q1 2026 in the United States?
Recovering autoimmune disease formulation and antimalarial stockpiling procurement lifted buying. Firmer synthesis intermediate costs raised the production floor. The market recovered to USD 34.3/KG from the H2 2025 oversupply low.
Chinese prices averaged USD 22.1/KG in Q1 2026, recovering from Q4 2025. Post-Lunar New Year antimalarial export and domestic restocking held the market near USD 22.1/KG.
Why did the price of Chloroquine Phosphate change in Q1 2026 in China?
Post-Lunar New Year antimalarial export and autoimmune restocking lifted buying. Firmer synthesis intermediate costs raised the production floor. The market recovered to USD 22.1/KG from the Q4 2025 low.
German prices averaged USD 41.6/KG in Q1 2026, recovering from H2 2025. Recovering autoimmune and antimalarial procurement and firmer synthesis and energy costs held the market near USD 41.6/KG.
Why did the price of Chloroquine Phosphate change in Q1 2026 in Germany?
Recovering autoimmune and antimalarial procurement maintained buying. Firmer synthesis intermediate and energy costs held the elevated production floor. The market recovered to USD 41.6/KG from the H2 2025 oversupply low.
Indian prices averaged USD 31.0/KG in Q1 2026, recovering from H2 2025. Growing antimalarial and autoimmune demand and firmer synthesis costs held the market near USD 31.0/KG.
Why did the price of Chloroquine Phosphate change in Q1 2026 in India?
Growing domestic antimalarial and autoimmune demand lifted procurement. Firmer synthesis intermediate costs raised the production floor. The market recovered to USD 31.0/KG from the H2 2025 oversupply low.
Global chloroquine phosphate prices declined through H2 2025 as post-COVID demand normalisation reduced strategic inventory needs before recovering firmly through Q1 and Q2 2026. The average fell from USD 28.50/KG in Q2 2025 to USD 27.93/KG in Q3 and USD 27.37/KG in Q4, then recovered to USD 28.46/KG in Q1 2026 and USD 30.45/KG in Q2 2026, a net gain of about 6.8% over the window. Post-COVID demand normalisation and antimalarial seasonal procurement cycles drove the pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 30.45 | +7.0% | ↑ Rising |
| Q1 2026 | 28.46 | +4.0% | ↑ Rising |
| Q4 2025 | 27.37 | -2.0% | ↓ Falling |
| Q3 2025 | 27.93 | -2.0% | ↓ Falling |
| Q2 2025 | 28.50 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Chloroquine phosphate prices declined through H2 2025 as global demand normalised from the elevated post-COVID strategic stockpiling levels. The global average opened at USD 29.15/KG in Q1 2025 and closed near USD 27.37/KG in Q4, a full-year decline of about 6.1%. Surplus inventory from pandemic-era production and reduced strategic stockpiling demand maintained downward pressure before the H1 2026 antimalarial season-driven recovery.
US prices fell from about USD 34.5/KG in Q1 2025 to USD 33.0/KG by Q4, a decline of 4.3%. Post-COVID stockpile drawdowns and normalising demand reduced procurement urgency through the year.
Chinese prices fell from roughly USD 22.0/KG in Q1 2025 to USD 21.2/KG by Q4, a decline of 3.6%. Post-pandemic production surplus and large domestic API capacity maintained the lowest price level throughout.
German prices fell from about USD 42.0/KG in Q1 2025 to USD 40.0/KG by Q4, a decline of 4.8%, the steepest in the dataset. Post-COVID stockpile normalisation and competitive Chinese API pricing maintained downward pressure.
Indian prices fell from roughly USD 31.0/KG in Q1 2025 to USD 29.8/KG by Q4, a decline of 3.9%. Post-pandemic demand normalisation and adequate domestic API production weighed on the market through the year.
Expert Market Research: Your Source for Real-Time Chloroquine Phosphate Price Intelligence
Expert Market Research tracks chloroquine phosphate prices continuously across every major producing and consuming region. The team traces causation through dichloroquinoline synthesis intermediate economics, antimalarial disease season procurement cycles, and regional API production capacity dynamics. Contact Expert Market Research today for chloroquine phosphate pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Antimalarial pharmaceutical formulations for Plasmodium vivax and chloroquine-sensitive malaria treatment and prophylaxis in tropical disease-endemic regions take the largest share. Autoimmune disease management in lupus and rheumatoid arthritis, strategic pandemic preparedness stockpiling, and veterinary antiprotozoal formulations also consume significant volumes.
The Q2 2026 average was USD 36.7/KG in the United States, USD 23.6/KG in China, USD 44.5/KG in Germany, and USD 33.2/KG in India. Germany remains the highest-priced market.
The global average rose from USD 28.46/KG in Q1 to about USD 30.45/KG in Q2, a gain of around 7.0%. Recovering antimalarial season procurement and firmer synthesis costs drove the H1 rebound from the H2 2025 post-COVID oversupply.
Global demand normalised from elevated post-COVID strategic stockpiling levels. Surplus inventory from pandemic-era production and competitive Chinese API pricing maintained downward pressure before the H1 2026 disease season procurement recovery.
The global average is expected in the USD 30.80 to 34.00/KG range for H2 2026, with continued firming as antimalarial disease season procurement grows and synthesis intermediate costs stay elevated.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on autoimmune and antimalarial demand, and China prices lowest on large domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to dichloroquinoline synthesis intermediate costs, antimalarial disease season procurement cycles from global health organisations, strategic stockpiling policy changes, and pandemic preparedness demand. Malaria outbreak reports from WHO and health ministry procurement schedules are key signals.
Asia Pacific leads with China and India holding the largest chloroquine phosphate API synthesis capacity, followed by Europe. Any synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time antimalarial and autoimmune formulation contracts around disease season cycles, build cover before peak procurement periods, and monitor WHO disease outbreak reports and health ministry stockpiling announcements as key demand signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.